Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy
Modern Pathology2013Vol. 27(2), pp. 271–280
Citations Over TimeTop 1% of 2013 papers
Jeffrey S. Ross, Kai Wang, Rami N. Al‐Rohil, Tipu Nazeer, Christine E. Sheehan, Geoff Otto, Jie He, Gary A. Palmer, Roman Yelensky, Doron Lipson, Siraj M. Ali, Sohail Balasubramanian, John A. Curran, Lazlo Garcia, Kristen Mahoney, Sean R. Downing, Matthew Hawryluk, Vincent A. Miller, Philip J. Stephens
Related Papers
- → Targeting the KRAS Pathway in Non-Small Cell Lung Cancer(2016)133 cited
- → Recurrent Chromosomal Copy Number Alterations in Sporadic Chordomas(2011)114 cited
- → Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4(2017)38 cited
- → Untangling the KRAS mutated lung cancer subsets and its therapeutic implications(2021)7 cited
- → Research progress of KRAS-targeted therapy for pancreatic ductal adenocarcinama(2018)